Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - SHORT-TERM DEBT
Short-term Debt KALV - KalVista Pharmaceuticals, Inc.
1.3 M
LAST VALUE
15.44%
2 YEAR CAGR
88.99%
5 YEAR CAGR
-8.20%
10 YEAR CAGR